The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis
Medicinal Research Reviews · 2023-11 · 43 (6) · 1878-1945
DOI: 10.1002/med.21966 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 05.05.2023. Verfasst von Carina Proença und 5 weiteren Autor:innen. Beteiligte Einrichtung: LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal. Hauptthemen laut MEDLINE: Neoplasms, MicroRNAs. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 208 Literaturangaben.
Abstract (Originalsprache)
One of the hallmarks of cancer is metastasis, a process that entails the spread of cancer cells to distant regions in the body, culminating in tumor formation in secondary organs. Importantly, the proinflammatory environment surrounding cancer cells further contributes to cancer cell transformation and extracellular matrix destruction. During metastasis, front‐rear polarity and emergence of migratory and invasive features are manifestations of epithelial‐mesenchymal transition (EMT). A variety of transcription factors (TFs) are implicated in the execution of EMT, the most prominent belonging to the Snail Family Transcriptional Repressor (SNAI) and Zinc Finger E‐Box Binding Homeobox (ZEB) families of TFs. These TFs are regulated by interaction with specific microRNAs (miRNAs), as miR34 and miR200. Among the several secondary metabolites produced in plants, flavonoids constitute a major group of bioactive molecules, with several described effects including antioxidant, antiinflammatory, antidiabetic, antiobesogenic, and anticancer effects. This review scrutinizes the modulatory role of flavonoids on the activity of SNAI/ZEB TFs and on their regulatory miRNAs, miR‐34, and miR‐200. The modulatory role of flavonoids can attenuate mesenchymal features and stimulate epithelial features, thereby inhibiting and reversing EMT. Moreover, this modulation is concomitant with the attenuation of signaling pathways involved in diverse processes as cell proliferation, cell growth, cell cycle progression, apoptosis inhibition, morphogenesis, cell fate, cell migration, cell polarity, and wound healing. The antimetastatic potential of these versatile compounds is emerging and represents an opportunity for the synthesis of more specific and potent agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LAQV, REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
ORCID-Profile: Carina Proença, Marisa Freitas, Daniela Ribeiro
Zitieren
APA
Proença, C., Freitas, M., Ribeiro, D., Rufino, A. T., Fernandes, E., & Ferreira de Oliveira, J. M. P. (2023). The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis. Medicinal Research Reviews, 43(6), 1878-1945. https://doi.org/10.1002/med.21966
Vancouver
Proença C, Freitas M, Ribeiro D, Rufino AT, Fernandes E, Ferreira de Oliveira JMP. The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis. Medicinal Research Reviews. 2023;43(6):1878-1945. doi:10.1002/med.21966
BibTeX
@article{Proena2023,
author = {Proença, Carina and Freitas, Marisa and Ribeiro, Daniela and Rufino, Ana T and Fernandes, Eduarda and Ferreira de Oliveira, José Miguel P},
title = {The role of flavonoids in the regulation of epithelial‐mesenchymal transition in cancer: A review on targeting signaling pathways and metastasis},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {6},
pages = {1878--1945},
doi = {10.1002/med.21966}
}
EUVIMED